Utah Medical Products (Utah Medical Products) Total Current Assets : $107.15 Mil (As of Mar. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Utah Medical Products Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Utah Medical Products's total current assets for the quarter that ended in Mar. 2024 was $107.15 Mil.

Utah Medical Products Total Current Assets Historical Data

The historical data trend for Utah Medical Products's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Utah Medical Products Total Current Assets Chart

Utah Medical Products Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Current Assets

Get a 7-Day Free Trial

54.89

62.26

73.16

89.92

106.27

Utah Medical Products Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Current Assets	Get a 7-Day Free Trial															95.11	98.81	101.85	106.27	107.15

Utah Medical Products Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Utah Medical Products's Total Current Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	92.868	+	3.39	+	9.582	+	0.429
	=	106.27

Utah Medical Products's Total Current Assets for the quarter that ended in Mar. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	93.808	+	3.591	+	9.24	+	0.50999999999999
	=	107.15

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Utah Medical Products (NAS:UTMD) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Utah Medical Products's Liquidation Value for the quarter that ended in Mar. 2024 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	93.808	-	7.699	+	0.75 * 3.591	+	0.5 * 9.24
=	93.42

Utah Medical Products Total Current Assets Related Terms

Thank you for viewing the detailed overview of Utah Medical Products's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Utah Medical Products (Utah Medical Products) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Utah Medical Products Inc (NAS:UTMD) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

UTM:Germany

Address

7043 South 300 West, Midvale, UT, USA, 84047

Website

http://www.utahmed.com

Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals as well as outpatient clinics and physicians offices.

Executives

Paul O Richins	director, officer: VP, Treasurer, Asst. Secretary	7043 SOUTH 300 WEST, MIDVALE UT 84047
Barbara A Payne	director
Ernst G Hoyer	director
Kevin L Cornwell	director, officer: Chairman, CEO, Secretary
Brian Koopman	officer: Principal Financial Officer	108 E 1700 S, BOUNTIFUL UT 84010
James H Beeson	director	7043 SOUTH 300 WEST, MIDVALE UT 84047
Greg A Leclaire	officer: Chief Financial Officer	5225 WILEY POST WAY, SUITE 500, SALT LAKE CITY UT 84116
Stephen W Bennett	director